Received Oct 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUAD) | SEQIRUS, INC. | 1 | 407280 | IM / RA |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | F9K3L | IM / LA |
Patient is 28 years old and pregnant. She is at 28 weeks' gestation and EDD is 12/24/2025. Patient received her Tdap and Influenza vaccines on 10/07/2025 at 03:00 pm. The Influenza vaccine given was the FLUAD HD instead of the regular dose vaccine. Patient did not state any symptoms at the time. We have been trying to contact patient via phone but have been unable to get in contact with her. CDC was notified and guidelines were given in regard to incident. Guidelines were emailed to me and this was forwarded to supervisor so that this could be given to patient. CDC case ID number was provided. Case ID #. Recommendation to contact the FDA was given from the CDC representative. Have not been able to get in contact with them due to hold time.
URI acute (09/25/2025)
PCOS
Prenatal 28 mg - 800 mcg tablet (1 tablet a day), Famotidine 20 mg tablet (1 tablet 2 times a day)
No known allergies
N/A